Incyte Corporation (INCY) vs Zimmer Biomet Holdings, Inc. (ZBH)
INCY leads on 11 of 15 compared metrics.
A side-by-side comparison of Incyte Corporation and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 21, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — INCY vs ZBH
growth of $100 · last 25yINCY +452.7%ZBH +204.7%INCY compounded faster
INCY ZBH
INCY vs ZBH: by the numbers
- •INCY is the larger company ($19.62B vs $17.02B market cap).
- •INCY trades at the lower earnings multiple (13.87 vs 22.85 P/E).
- •INCY converts more revenue to profit (26.71% vs 9.05% net margin).
- •INCY grew revenue faster over the past five years (14.68% vs 4.21% CAGR).
- •ZBH pays a dividend (1.09% yield) while INCY does not currently pay one.
Which is better, INCY or ZBH?
Metric tally: INCY 11 · ZBH 4It depends on what you're optimizing for:
ValueINCY(lower P/E)
GrowthINCY(faster 5Y revenue CAGR)
QualityINCY(higher ROIC)
Metrics side by side
Valuation
| Metric | INCY | ZBH |
|---|---|---|
| P/E ratio | 13.87● | 22.85 |
| Forward P/E | 11.04 | 9.77● |
| P/S ratio | 3.79 | 2.05● |
| P/B ratio | 3.66 | 1.36● |
| PEG ratio | 0.65 | — |
| EV / EBITDA | 9.03● | 11.00 |
| FCF yield | 7.14% | 10.66%● |
Profitability
| Metric | INCY | ZBH |
|---|---|---|
| Gross margin | 92.48%● | 70.03% |
| Operating margin | 27.05%● | 15.61% |
| Net margin | 26.71%● | 9.05% |
| ROE | 25.79%● | 6.01% |
| ROIC | 20.58%● | 5.48% |
Dividends
| Metric | INCY | ZBH |
|---|---|---|
| Dividend yield | — | 1.09% |
| Payout ratio | — | 26.97% |
Growth (annualized)
| Metric | INCY | ZBH |
|---|---|---|
| Revenue CAGR (5Y) | 14.68%● | 4.21% |
| EPS CAGR (5Y) | 21.19%● | -7.05% |
| FCF CAGR (5Y) | 20.60%● | 15.41% |
| Total return CAGR (5Y) | 3.19%● | -9.82% |
Frequently asked
- Which is better, INCY or ZBH?
- It depends on your goal. value: INCY (lower P/E); growth: INCY (faster 5Y revenue CAGR); quality: INCY (higher ROIC). Across all compared metrics, INCY leads 11 to 4.
- Is INCY or ZBH cheaper?
- On trailing earnings, INCY is cheaper: INCY trades at a 13.87 P/E and ZBH at 22.85.
- Which has grown faster, INCY or ZBH?
- Over the past five years, INCY grew revenue faster — INCY at a 14.68% CAGR versus ZBH at 4.21%.
- Does INCY or ZBH pay a bigger dividend?
- ZBH pays a dividend (1.09% yield) while INCY does not currently pay one.
- Is INCY or ZBH more profitable?
- INCY runs the higher net margin — INCY at 26.71% versus ZBH at 9.05%.
- Which has been the better investment, INCY or ZBH?
- Over the past 10-year, INCY delivered the higher annualized total return — INCY at 2.45% versus ZBH at -1.68%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Incyte P/E ratioZimmer Biomet P/E ratioIncyte dividend yieldZimmer Biomet dividend yieldIncyte ROEZimmer Biomet ROEIncyte operating marginZimmer Biomet operating marginIncyte revenue growthZimmer Biomet revenue growthIncyte free cash flowZimmer Biomet free cash flow
Incyte & Zimmer Biomet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 21, 2026.